Related Experiment Video
Updated: Aug 20, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Diphenhydramine induced acute dystonia: a case report
Danielle Abou Khater1, Rafi Daou1, Ali Al Dailaty2
1Department of Emergency Medicine, Lebanese American University Medical Center, Beirut, Lebanon.
Diphenhydramine can cause acute dystonic reactions, a rare but serious side effect. This case highlights the need for further research into drug-induced dystonia and its contributing factors.
Area of Science:
- Emergency Medicine
- Clinical Pharmacology
- Neuroscience
Background:
- Acute dystonia is a significant challenge in emergency settings.
- Drug-induced dystonia is infrequently documented in medical literature.
- Diphenhydramine is rarely implicated as a cause of dystonic reactions.
Observation:
- A 25-year-old female experienced an acute dystonic reaction after receiving intravenous diphenhydramine for an allergic reaction.
- The patient was administered 25 mg of intravenous diphenhydramine.
- The reaction manifested shortly after drug administration.
Findings:
- Diphenhydramine can precipitate acute dystonic reactions, even at standard doses.
- This adverse reaction, though rare, is severe and requires prompt management.
- The patient was successfully treated with diazepam and monitored.
Implications:
- Diphenhydramine-induced acute dystonia underscores the importance of recognizing idiosyncratic drug reactions.
- Further investigation into drug metabolism and patient phenotypes is warranted to understand susceptibility to such adverse events.
- Clinicians should be vigilant for dystonic reactions when prescribing diphenhydramine, especially in emergency situations.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
10:05Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...